European bioregions : strengths and partnership strategies ... · The Bioregion of Catalonia •...
Transcript of European bioregions : strengths and partnership strategies ... · The Bioregion of Catalonia •...
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
European bioregions : strengths and partnership
strategies. The bioXclusters example BioPartnering Latin America – cluster forum – september 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
Contents
Who we are
Our goals
Our activities
Wha we can offer
What we will represent in
the future
23 April, 2013 2
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
mutual learning
exchange of good practice
joint business opportunities
development of common strategies
exchange of qualified staff
mobility of firms
sharing incubation facilities
mutually sharing access to networks and international partnerships
access to international markets and business development in new market
mutually exchange technical competences
share research infrastructure and production facilities
economies of scale
Why to cooperate?
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
May 2013 4
bioXclusters Regional
clusters
partnership
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
5
Who are we?
bioXclusters is a European initiative, funded by the European Commission,
uniting 4 regions in Europe with one single approach:
Supporting the competitiveness of European clusters’ SMEs by facilitating internationalisation and access to global markets
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
May 2013 6
Our assets
MAIN
SECTORS
Biotechnology
Health care
Biomedicine
Regenerative Med.
Biopharmaceutical
Diagnostics
THERAPEUTIC
AREAS
Oncology
Cardiovascular
Infectious diseases
Inflamatory diseases
Neurological diseases
Autoimmune diseases
TECHNOLOGY
SPECIALITIES
Personalised Medicine
Nanomedicine
Targeted therapies
Drug Development
Medical technologies
Diagnostics Solutions
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
May 2013 7
Four European
partners
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
The Bioregion of
Catalonia
• Main biotech hub in
Spain
• 480 companies
• 435 Research Groups
• 10 Universities
• 3 Large-scale R&D
Infrastructures
• 15 university hospitals
• 20 Science parks
Visit us in www.biocat.cat
Follow us on twitter
(@biocat.en) and
Catalonia (Spain)
with capital in
Barcelona
INTERNATIONALIZATION/GLOBALIZATION:
Facilitating access to markets through:
• Network of local contacts in foreign markets
• Agreements with science parks and other
organizations
Main Interests:
• USA
• Asia (China, Japan & India)
• South America
Member of CEBR – Council of
European Bioregions & EDCA
Main Therapeutic Areas
• Oncology
• Neurosciences
• Cardiovascular
• Dermatology
Technological
Strengths
• Nanobiomedicine
• Genomics &
Structural Biology
• Drug Design
• Bioinformatics
Fostering talent
www.moebio.org
Organization of
BIoEurope Spring
2010 & 2013
1997 – Barcelona Science
Park was created
2006 – Creation of Biocat
– Private Foundation
Promotes and develops
life sciences in Catalonia
2013 – Launch of the First
Edition of Design Health
Barcelona program
d·HEALTH Barcelona
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
Bavaria (Germany)
and Greater Munich
1989 - Foundation of first
biotech SME
1997- Establishment of
BioM cluster organisation
2010 – Start of Munich
Initiative for Personalized
Medicine (www.m4.de)
338 biotech &
pharma companies: 178 biotech SMEs
37 biotech non-SMEs
37 pharma companies
86 CROs & suppliers
26.000 employees
in total,
4.300 in biotech SMEs
INTERNATIONALIZATION / GLOBALIZATION:
Growth through partnerships and
collaborations in Europe and worldwide.
Main interest of members:
Asia (China & Japan) and USA
Member of CEBR – Council of European
Bioregions
BioM Biotech Cluster Development GmbH www.bio-m.org
Personalised Medicine &
Targeted Therapies,
Therapeutics &
Diagnostics, Devices,
Analytics, Informatics
Oncology,
Cardiovascular diseases
Autoimmune diseases
Close collaboration with
regional medtech network
“m4 Initiative for
Personalized
Medicine & Targeted
Therapies”:
100 mio € for 5 years,
35 R&D projects,
5 infrastructure projects,
m4 Award for start-ups,
collaborations between
SMEs and academia /
hospitals.
Germany
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
Piemonte region
(Italy)
Main city Torino
(Turin)
1999- Science park
creation
2009-Cluster
initiative inception
400-in total
270 health care
7.000 employees
SME No: 95%
27 MNC
3900 scientist in
R&D institutions
INTERNATIONALIZATION/GLOBALIZATION:
Growth through partnerships and collaborations 14+ MOU with international actors
147 SMEs supported (last 4 years)
10+ international projects ongoing and realized
CEBR – Council of European Bioregions
2 Multinational corporations as shareholder of
the science park
Metaclustering approach to have
critical mass based on
complementarities
bioPmed health care
cluster
Bioindustry Park
Silvano Fumero SpA
Science park
www.biopmed.eu
www.bioindustrypark.eu
• Personalised health
care/Converging
technologies
• Innovative biomedical
devices (Prosthesis)
• Imaging
• Regenerative
medicine
• Oncology, CNS,
Autoimmune diseases
• Start-up creation
ALISEI Member Bioeurope Spring 2014 in Torino 30 R&D projects launched involving 70 actors in the last 4 years
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
LYONBIOPOLE Rhone-Alpes BioCluster www.lyonbiopole.com
Rhone-Alpes
Region (France)
Main cities
Lyon & Grenoble
+ 500 companies in
health care
+ 30 000 employees
+ 4 000 scientists
>4 World Class leaders:
bioMérieux, Sanofi, BD,
Merial.
>8 International R&D
Infrastructures
>130 official members
> 134 R&D projects =
total of € 667 million
INTERNATIONALIZATION/GLOBALIZATION:
>Internationalization based on a dual
approach: interclustering and support to SMEs.
>3 main target markets: North America (USA +
Canada), Brazil & China
>One representative based in Shanghai
>Member of CEBR – Council of European
Bioregions & EDCA
>In 2012: + 50 companies supported
& 6 international trade missions
Infectious diseases
Immune Disorders
Cancers
Personalized medicine
Biotherapies & Vaccines
Diagnostics
Delivery systems
Devices
Close collaboration with
regional medtech network European Network on System Biology & Medicine
>2005 – Establishment
of the French cluster
policy and creation of
Lyonbiopole
>2012 – EU Bronze
Label Awarded and
Lyonbiopole assessed
as the most performing
French BioCluster
7 500 sq.m of biomanufacturing & bioanalysis labs
1 920sq.m of BSL 2/3 Labs
Technological Research Institute on Infectious Diseases & Microbiology
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
12
Our goals and
activities
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
13
Brazil China US
With 2 main objectives…
3 target markets…
Supporting European SMEs’ internationalisation and creating a
single European entry point for global biotech & health players
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
Hosting Eduardo Soares, CEO of Biominas (Minas Gerais), in Europe (April 2012) 1 country report (Sept 2012) Mission to Sao Paulo & Rio de Janeiro (Sept 2012)
Institut Butantan, CIETEC, FAPESP, FioCruz, BIORIO, Recepta, Pitanga, FINEP Participation in BioPartnering Latin America 2012
Signature of an MoU for 2 years with Health Foundation and Technological Park of Ribeirão Preto region, Brazil (March 25, 2013)
Signature with MOU with Biorio (September 2013)
Mission with European Commission (Sept 2013). Participation in BioPartnering Latin America 2013
Main activities and achievements up to now
14
Brazil
China
US
Hosting Gao Ronghui, CEO of G-med Consulting (Shanghai), in Europe (Jan 2013) 1 country report (Jan 2013) Mission to Shanghai region, with around 15 EU companies from 4 countries (May 2013):
Co-organisation of a Sino-European Partnering Day Participation in BioForum conference and visits (parks, hospitals, companies) Signatures of MoUs with Zhangjiang Park + Juke Biotech Park
Hosting Karin Hollerbach, CEO Taku Group (Silicon Valley) in Europe (April 2013) 1 country report in progress (September 2013) Mission with EU companies planned (October 2013)
May 2013
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
May 2013 15
What
can we offer?
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
What can we offer?
May 2013 16
bioXclusters, a unique metacluster, your entry point to access the
European healthcare market
Expertise on European biotech and
medtech market opportunities and
regulations
Access to high quality innovative players
(SMEs & academic research partners)
Collaboration potential in many innovative
R&D and drug development projects
High-tech solutions for the Chinese
healthcare market
Activities are realised in complementarity
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
May 2013 17
Building win-win exchanges
Providing European market key data and knowing
better foreign markets
Supporting European SMEs to reach target markets,
create new technological and commercial
reciprocal opportunities
Identifying new partners between respective
countries’ players (companies, academics, clusters)
Building long-term relations between European
clusters and foreign counterparts
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
bioXclusters contact details
May 2013 20
Emilie Romeo Project manager [email protected] +33 (0)4 72 76 53 30 www.lyonbiopole.com
Dr. Daniela Tonn International Affairs & Training [email protected] +49 (0)89 89 96 79 15 www.bio-m.org
Fabrizio Conicella Director Business Development and Internation Projects conicella@bioindustry park.it +39(0) 125 561.311 www.biopmed.eu
Elisabetta Schena International Cluster Development Project Manager [email protected] +33 (0)4 26 73 68 04 www.erai.org
Mamen Marti Head of Internationalisation (Business Development) [email protected] +34 (0)93 3103330 www.biocat.cat
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
EU Initiative Promoting SME Internationalisation Through Clusters
Thank you for your attention
Visit us at www.bioXclusters.eu
Follow us on Twitter (@bioXclusters) and Linkedin
This initiative is supported by the European Commission’s Directorate-General for Enterprise and Industry and financed under the Competitiveness and Innovation Framework Programme (CIP)
Partners: Coordinated by:
May 2013